Kumar, A.; Tohmasi, S.; Eaton, D.B., Jr.; Seyoum, N.; Brandt, W.S.; Thomas, T.S.; Schoen, M.W.; Rossetti, N.E.; Chang, S.-H.; Yan, Y.;
et al. Real-World Adoption of Adjuvant Therapies for Resected Stage IB–III Non-Small-Cell Lung Cancer. Cancers 2025, 17, 2961.
https://doi.org/10.3390/cancers17182961
AMA Style
Kumar A, Tohmasi S, Eaton DB Jr., Seyoum N, Brandt WS, Thomas TS, Schoen MW, Rossetti NE, Chang S-H, Yan Y,
et al. Real-World Adoption of Adjuvant Therapies for Resected Stage IB–III Non-Small-Cell Lung Cancer. Cancers. 2025; 17(18):2961.
https://doi.org/10.3390/cancers17182961
Chicago/Turabian Style
Kumar, Arvind, Steven Tohmasi, Daniel B. Eaton, Jr., Nahom Seyoum, Whitney S. Brandt, Theodore S. Thomas, Martin W. Schoen, Nikki E. Rossetti, Su-Hsin Chang, Yan Yan,
and et al. 2025. "Real-World Adoption of Adjuvant Therapies for Resected Stage IB–III Non-Small-Cell Lung Cancer" Cancers 17, no. 18: 2961.
https://doi.org/10.3390/cancers17182961
APA Style
Kumar, A., Tohmasi, S., Eaton, D. B., Jr., Seyoum, N., Brandt, W. S., Thomas, T. S., Schoen, M. W., Rossetti, N. E., Chang, S.-H., Yan, Y., Patel, M. R., Malone, S., Tokaz, M. C., Meyers, B. F., Kozower, B. D., Puri, V., & Heiden, B. T.
(2025). Real-World Adoption of Adjuvant Therapies for Resected Stage IB–III Non-Small-Cell Lung Cancer. Cancers, 17(18), 2961.
https://doi.org/10.3390/cancers17182961
